Jim Simons Adicet Bio, Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,512,600 shares of ACET stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,512,600

Previous 1,049,000 44.19%

Holding current value

$1.97 Million

Previous $2.47 Million 25.76%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.21 - $2.4 $560,956 - $1.11 Million	463,600 Added 44.19%	1,512,600 $1.83 Million
Q1 2024 May 13, 2024	BUY	$1.76 - $3.45 $497,024 - $974,280	282,400 Added 36.84%	1,049,000 $2.47 Million
Q4 2023 Feb 13, 2024	BUY	$1.11 - $1.89 $99,456 - $169,344	89,600 Added 13.23%	766,600 $1.45 Million
Q3 2023 Nov 14, 2023	BUY	$1.37 - $3.4 $639,237 - $1.59 Million	466,597 Added 221.76%	677,000 $927,000
Q2 2023 Aug 11, 2023	SELL	$2.13 - $7.13 $224,495 - $751,480	-105,397 Reduced 33.37%	210,403 $511,000
Q1 2023 May 12, 2023	BUY	$5.52 - $9.23 $1.58 Million - $2.64 Million	286,100 Added 963.3%	315,800 $1.82 Million
Q4 2022 Feb 13, 2023	BUY	$7.72 - $21.27 $229,284 - $631,719	29,700 New	29,700 $266,000
Q2 2022 Aug 12, 2022	BUY	$10.26 - $20.81 $1.29 Million - $2.61 Million	125,500 New	125,500 $1.83 Million
Q4 2021 Feb 11, 2022	SELL	$7.37 - $17.49 $311,139 - $738,375	-42,217 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$6.29 - $9.93 $248,348 - $392,066	-39,483 Reduced 48.33%	42,217 $331,000
Q2 2021 Aug 13, 2021	BUY	$9.19 - $15.93 $566,104 - $981,288	61,600 Added 306.47%	81,700 $841,000
Q1 2021 May 13, 2021	BUY	$12.12 - $17.17 $243,611 - $345,117	20,100 New	20,100 $263,000

Others Institutions Holding ACET

# of Institutions

Shares Held

66.3M

Call Options Held

4.3K

Put Options Held

36.3K

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $52M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account